Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Orlistat

Effects of Weight Loss in Obese Difficult-to-treat Asthmatics

Empros Pharma AB · Phase 3 · Completed · Enrollment 33

NCT01047657

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

No selected arm reports a responder percent.

Show as table
Arm≥5%≥10%≥15%≥20%
weight lossn/rn/rn/rn/r
Controln/rn/rn/rn/r

Not shown

  • weight loss: endpoint not reported
  • Control: endpoint not reported